← Compare landing
LOTTE Biologics vs Merck KGaA
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | LOTTE Biologics | Merck KGaA |
|---|---|---|
| Summary | LOTTE Biologics offers biologics CDMO services spanning process and analytical development, antibody manufacturing from clinical to commercial GMP, and bioconjugate manufacturing. Its operations are based at campuses in Syracuse, New York and Songdo, Incheon. | Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea. |
| Services |
| Data not yet provided. |
| Modalities |
| Data not yet provided. |
| Development capabilities |
| Data not yet provided. |
| Manufacturing capabilities |
| Data not yet provided. |
| Locations |
|
|
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/lotte-biologics/merck-kgaa.md